aspsirna0960 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna0960
siRNA Name: K12-Arg135Thr-13
Gene:Keratin 12 (KRT12)
Disease:Meesmann epithelial corneal dystrophy (MECD)
Wild allele/target (5'->3'): AUGAUAGAUUAGCUUCCUA
Mutant allele/target (5'->3'):AUGAUACAUUAGCUUCCUA
Target Mutation: c.404G>C,p.Arg135Thr
Wild siRNA (As strand):UACUAUCUAAUCGAAGGAU
ASP-siRNA (As strand):UACUAUGUAAUCGAAGGAU
Mismatch position in siRNA: G13C
Mutant allele (5'->3'): AUGAUACAUUAGCUUCCUA
ASP-siRNA (As strand):UACUAUGUAAUCGAAGGAU
ASP-siRNA efficacy for mutant allele:92
Wild allele (5'->3'): AUGAUAGAUUAGCUUCCUA
ASP-siRNA (As strand):UACUAUGUAAUCGAAGGAU
ASP-siRNA efficacy for wild allele:0
Percentage discrimination for ASP-siRNA:92
Wild allele (5'->3'): AUGAUAGAUUAGCUUCCUA
Wild siRNA (As strand):UACUAUCUAAUCGAAGGAU
Wild sirna efficacy for wild allele:NA
Wild allele (5'->3'): AUGAUAGAUUAGCUUCCUA
ASP-siRNA (As strand):UACUAUGUAAUCGAAGGAU
Wild sirna efficacy for mutant allele:NA
Percentage discrimination for wild siRNA:NA
Concentration:0.25nM, 5nM
Orientation:Sense
Mismatch in:siRNA
UniProt ID: Q99456
Target sequence: GAAAAAGAAACTATGCAAAATCTTAATGATAG
Genbank Accesion: NM_000223.3
Cell-line: AD293
Experimental technique used: Dual luciferase reporter assay
Transfection method: Lipofectamine 2000
siRNA expression method: MWG Biotech AG
Post-transfection duration: 72 hours
OMID ID: 122100
KEGG disease ID:H00726
Reference:23233254

.
.
.
.
.
.
.
.
.
.
.

.

.

.